Latest Posts › United States v Arthrex Inc

Share:

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions: United States v. Arthrex, 141 S. Ct. 1970 (2021)

Arthrex appealed a final written decision from an inter partes review (IPR) where the U.S. Patent Trial and Appeal Board (PTAB) found all challenged claims of its patent anticipated. On appeal, Arthrex argued that the...more

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2021 Decisions

[co-author: Jamie Dohopolski] Last year, the continued global COVID-19 pandemic forced American courts to largely continue the procedures set in place in 2020. The U.S. Court of Appeals for the Federal Circuit was no...more

2/9/2022  /  § 314(d) , 35 U.S.C. §315(e)(1) , Absolute Intervening Rights Doctrine , Abuse of Discretion , Administrative Patent Judges , Administrative Procedure Act , America Invents Act , Appeals , Appointments Clause , Arbitrary and Capricious , Article of Manufacture , Assignor Estoppel , Burden of Proof , Claim Construction , Collateral Estoppel , Commercial Success , Confidential Information , Constitutional Challenges , Demand Letter , Denial of Institution , Design Patent , Director of the USPTO , Dismissals , Doctrine of Prosecution Disclaimer , Due Process , Equitable Estoppel , Estoppel , Evidence , Ex Partes Reexamination , Executive Branch , Executive Powers , Federal Rules of Evidence , Final Written Decisions , Forum Selection , FRCP 52(c) , GATT , Inferior Officers , Intellectual Property Litigation , Intellectual Property Protection , Inter Partes Reexamination , Inter Partes Review (IPR) Proceeding , International Trade Commission (ITC) , Intervening Acts , Inventions , Issue Preclusion , Judicial Review , Lack of Authority , Lack of Jurisdiction , Likelihood of Success , Minerva Surgical Inc. v Hologic Inc. , Motion for Summary Judgment , Motivation to Combine , Nexus , Non-Disclosure Agreement , Nonobvious , Obviousness , Ornamental Design , Parallel Proceedings , Patent Applications , Patent Filings , Patent Infringement , Patent Litigation , Patent Prosecution , Patent Trial and Appeal Board , Patent Validity , Patents , Petition for Writ of Certiorari , Pharmaceutical Patents , Post-Grant Review , Pre-GATT , Preliminary Injunctions , Principle Officers , Printed Publications , Prior Art , Real Party in Interest , Remand , Reversal , Rule 36 , Scope of Review , SCOTUS , Section 325(d) , Sua Sponte , Substantial Evidence , Totality of Evidence , United States v Arthrex Inc , USPTO , Vacated , Writ of Mandamus

PTAB Strategies and Insights - July 2021: Arthrex: One Month Later

Following the Supreme Court’s decision in United States v. Arthrex, the Federal Circuit issued requests for briefing regarding the decision’s impact in pending PTAB appeals in which an Appointments Clause challenge had been...more

What You Should Know About the Supreme Court's Decision in Arthrex

The US Supreme Court held in United States v. Arthrex that administrative patent judges’ ability to render final decisions on patentability on behalf of the Executive Branch is “incompatible with their status as inferior...more

Federal Circuit Appeals from the PTAB and ITC: Summaries of Key 2020 Decisions: United States v. Arthrex, Inc., No. 19-1434 (U.S.)

In October 2020, the Supreme Court agreed to review the Federal Circuit’s holding in Arthrex Inc. v. Smith & Nephew Inc., 941 F.3d 1320 (Fed. Cir. 2019), that the scheme for appointing the Patent Trial and Appeal Board’s...more

9 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide